Series: Pragmatic trials and real world evidence: Paper 3. Patient selection challenges and consequences-Reference-Cited by-同舟云学术

Series: Pragmatic trials and real world evidence: Paper 3. Patient selection challenges and consequences

Published:2017-09 Issue: Volume:89 Page:173-180
ISSN:0895-4356
Container-title:Journal of Clinical Epidemiology
language:en
Short-container-title:Journal of Clinical Epidemiology

Author:

Oude Rengerink Katrien,Kalkman Shona^ORCID,Collier Susan,Ciaglia Antonio^ORCID,Worsley Sally D.,Lightbourne Alison,Eckert Laurent,Groenwold Rolf H.H.,Grobbee Diederick E.,Irving Elaine A.

Publisher

Elsevier BV

Subject

Epidemiology

Reference49 articles.

1. Explanatory and pragmatic attitudes in therapeutical trials;Schwartz;J Clin Epidemiol,2009

2. Explanatory and pragmatic clinical trials: a primer and application to a recent asthma trial;Sackett;Pol Arch Med Wewn,2011

3. Series: Pragmatic trials and real world evidence: Paper 1. Introduction;Zuidgeest;J Clin Epidemiol,2017

4. A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results;Kennedy-Martin;Trials,2015

5. What influences recruitment to randomized controlled trials? A review of trials funded by two UK funding agencies;McDonald;Trials,2006

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Promoting serious illness conversations in primary care through telehealth among persons living with cognitive impairment;Journal of the American Geriatrics Society;2024-07-23

2. The professional perception of the International Caries Classification and Management System (ICCMS): a pragmatic randomised clinical trial;British Dental Journal;2024-06-20

3. Statistical Considerations for the Design and Analysis of Pragmatic Trials in Aging Research;Geriatrics;2024-06-04

4. Methods for pragmatic randomized clinical trials of pain therapies: IMMPACT statement;Pain;2024-05-03

5. ESMO Guidance for reporting oncology real-world evidence (GROW);Real-World Data & Evidence;2024-04-13